Determination of galantamine in human plasma by LC-MS/MS using carbamazepine as an internal standard: Method validation and application to a pharmacokinetic study of galantamine hydrobromide prolonged-release capsules in healthy Thai volunteers

A rapid, sensitive and reliable LC-MS/MS method for the determination of galantamine in plasma was developed and validated for the pharmacokinetic study of galantamine hydrobromide 8 mg prolonged-release capsules. The plasma sample was prepared by simple liquid-liquid extraction with dichloromethane...

Full description

Bibliographic Details
Main Authors: Darunee Hongwiset, Songwut Yotsawimonwat, Chokchai Wongsinsup, Saowarunee Sangsrijan, Chuleegone Sornsuvit
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:Cogent Medicine
Subjects:
Online Access:http://dx.doi.org/10.1080/2331205X.2020.1804093
_version_ 1811227553523826688
author Darunee Hongwiset
Songwut Yotsawimonwat
Chokchai Wongsinsup
Saowarunee Sangsrijan
Chuleegone Sornsuvit
author_facet Darunee Hongwiset
Songwut Yotsawimonwat
Chokchai Wongsinsup
Saowarunee Sangsrijan
Chuleegone Sornsuvit
author_sort Darunee Hongwiset
collection DOAJ
description A rapid, sensitive and reliable LC-MS/MS method for the determination of galantamine in plasma was developed and validated for the pharmacokinetic study of galantamine hydrobromide 8 mg prolonged-release capsules. The plasma sample was prepared by simple liquid-liquid extraction with dichloromethane. Chromatographic separation was performed on a Hypurity C4 (150 x 4.6 mm, particle size 5.0 µm) using isocratic acetonitrile: 10 mM ammonium formate (90:10) as a mobile phase at a flow rate of 0.8 mL/min. Galantamine was detected by mass spectrometry using the electrospray ion source in the selected reaction monitoring mode. Carbamazepine was used as an internal standard (IS). The extraction recovery was 105.45–111.84% for galantamine and 107.35% for IS. Linearity was found within the calibration range of 0.39–62.5 ng/mL. The intra-day and inter-day accuracy were achieved with the mean concentrations of the quality control samples as 91.92–100.97% and 94.29–102.07%, respectively. The intra-day and inter-day precision were expressed as %CV of 1.34–6.11% and 3.31–5.01%. The long-term stability study showed that galantamine was stabled in plasma for at least 50 days at −30°C. This validated method was proven to be useful for the pharmacokinetic study of galantamine hydrobromide in healthy Thai volunteers. After the oral administration of one tablet in fasting conditions, Tmax and Cmax were found to be 5.61 ± 1.71 hours and 25.96 ± 4.18 ng/mL, respectively, whereas T1/2 was found to be 9.89 ± 1.48 hours.
first_indexed 2024-04-12T09:43:12Z
format Article
id doaj.art-8ccbdaaa7c9640e2b7265e9aca384625
institution Directory Open Access Journal
issn 2331-205X
language English
last_indexed 2024-04-12T09:43:12Z
publishDate 2020-01-01
publisher Taylor & Francis Group
record_format Article
series Cogent Medicine
spelling doaj.art-8ccbdaaa7c9640e2b7265e9aca3846252022-12-22T03:38:00ZengTaylor & Francis GroupCogent Medicine2331-205X2020-01-017110.1080/2331205X.2020.18040931804093Determination of galantamine in human plasma by LC-MS/MS using carbamazepine as an internal standard: Method validation and application to a pharmacokinetic study of galantamine hydrobromide prolonged-release capsules in healthy Thai volunteersDarunee Hongwiset0Songwut Yotsawimonwat1Chokchai Wongsinsup2Saowarunee Sangsrijan3Chuleegone Sornsuvit4Chiang Mai UniversityChiang Mai UniversityChiang Mai UniversityChiang Mai UniversityChiang Mai UniversityA rapid, sensitive and reliable LC-MS/MS method for the determination of galantamine in plasma was developed and validated for the pharmacokinetic study of galantamine hydrobromide 8 mg prolonged-release capsules. The plasma sample was prepared by simple liquid-liquid extraction with dichloromethane. Chromatographic separation was performed on a Hypurity C4 (150 x 4.6 mm, particle size 5.0 µm) using isocratic acetonitrile: 10 mM ammonium formate (90:10) as a mobile phase at a flow rate of 0.8 mL/min. Galantamine was detected by mass spectrometry using the electrospray ion source in the selected reaction monitoring mode. Carbamazepine was used as an internal standard (IS). The extraction recovery was 105.45–111.84% for galantamine and 107.35% for IS. Linearity was found within the calibration range of 0.39–62.5 ng/mL. The intra-day and inter-day accuracy were achieved with the mean concentrations of the quality control samples as 91.92–100.97% and 94.29–102.07%, respectively. The intra-day and inter-day precision were expressed as %CV of 1.34–6.11% and 3.31–5.01%. The long-term stability study showed that galantamine was stabled in plasma for at least 50 days at −30°C. This validated method was proven to be useful for the pharmacokinetic study of galantamine hydrobromide in healthy Thai volunteers. After the oral administration of one tablet in fasting conditions, Tmax and Cmax were found to be 5.61 ± 1.71 hours and 25.96 ± 4.18 ng/mL, respectively, whereas T1/2 was found to be 9.89 ± 1.48 hours.http://dx.doi.org/10.1080/2331205X.2020.1804093galantaminelc-ms/mshuman plasmavalidationpharmacokinetic study
spellingShingle Darunee Hongwiset
Songwut Yotsawimonwat
Chokchai Wongsinsup
Saowarunee Sangsrijan
Chuleegone Sornsuvit
Determination of galantamine in human plasma by LC-MS/MS using carbamazepine as an internal standard: Method validation and application to a pharmacokinetic study of galantamine hydrobromide prolonged-release capsules in healthy Thai volunteers
Cogent Medicine
galantamine
lc-ms/ms
human plasma
validation
pharmacokinetic study
title Determination of galantamine in human plasma by LC-MS/MS using carbamazepine as an internal standard: Method validation and application to a pharmacokinetic study of galantamine hydrobromide prolonged-release capsules in healthy Thai volunteers
title_full Determination of galantamine in human plasma by LC-MS/MS using carbamazepine as an internal standard: Method validation and application to a pharmacokinetic study of galantamine hydrobromide prolonged-release capsules in healthy Thai volunteers
title_fullStr Determination of galantamine in human plasma by LC-MS/MS using carbamazepine as an internal standard: Method validation and application to a pharmacokinetic study of galantamine hydrobromide prolonged-release capsules in healthy Thai volunteers
title_full_unstemmed Determination of galantamine in human plasma by LC-MS/MS using carbamazepine as an internal standard: Method validation and application to a pharmacokinetic study of galantamine hydrobromide prolonged-release capsules in healthy Thai volunteers
title_short Determination of galantamine in human plasma by LC-MS/MS using carbamazepine as an internal standard: Method validation and application to a pharmacokinetic study of galantamine hydrobromide prolonged-release capsules in healthy Thai volunteers
title_sort determination of galantamine in human plasma by lc ms ms using carbamazepine as an internal standard method validation and application to a pharmacokinetic study of galantamine hydrobromide prolonged release capsules in healthy thai volunteers
topic galantamine
lc-ms/ms
human plasma
validation
pharmacokinetic study
url http://dx.doi.org/10.1080/2331205X.2020.1804093
work_keys_str_mv AT daruneehongwiset determinationofgalantamineinhumanplasmabylcmsmsusingcarbamazepineasaninternalstandardmethodvalidationandapplicationtoapharmacokineticstudyofgalantaminehydrobromideprolongedreleasecapsulesinhealthythaivolunteers
AT songwutyotsawimonwat determinationofgalantamineinhumanplasmabylcmsmsusingcarbamazepineasaninternalstandardmethodvalidationandapplicationtoapharmacokineticstudyofgalantaminehydrobromideprolongedreleasecapsulesinhealthythaivolunteers
AT chokchaiwongsinsup determinationofgalantamineinhumanplasmabylcmsmsusingcarbamazepineasaninternalstandardmethodvalidationandapplicationtoapharmacokineticstudyofgalantaminehydrobromideprolongedreleasecapsulesinhealthythaivolunteers
AT saowaruneesangsrijan determinationofgalantamineinhumanplasmabylcmsmsusingcarbamazepineasaninternalstandardmethodvalidationandapplicationtoapharmacokineticstudyofgalantaminehydrobromideprolongedreleasecapsulesinhealthythaivolunteers
AT chuleegonesornsuvit determinationofgalantamineinhumanplasmabylcmsmsusingcarbamazepineasaninternalstandardmethodvalidationandapplicationtoapharmacokineticstudyofgalantaminehydrobromideprolongedreleasecapsulesinhealthythaivolunteers